DR. INFO and OpenEvidence, side by side
Available in Austria
DR. INFO Yes, on the web and the iPhone app
OpenEvidence No, access from the EU ended 28 April 2026
Answers in German
DR. INFO Yes, in the language you ask in; German interface
OpenEvidence No, English only
How it answers
DR. INFO A written answer built from retrieved guidelines and literature, each statement cited
OpenEvidence A written answer with citations, US-oriented sources
Data hosting
DR. INFO European Union, under GDPR
OpenEvidence United States
Guideline sources
DR. INFO European and national guidelines, retrieved per question, including the German-language S3 guidelines with Austrian participation
OpenEvidence US-centred
Drug information
DR. INFO FDA and EMA authorised sources, EMA SmPC; the Austria-Codex remains the Austrian reference
OpenEvidence US sources
Documentation
DR. INFO Scribe with SOAP notes and discharge letters in the same product
OpenEvidence None
Regulatory status
DR. INFO CE marked medical device under EU MDR 2017/745, which applies directly in Austria
OpenEvidence Not CE marked
HealthBench Hard (same 100 examples)
DR. INFO 0.72
OpenEvidence 0.49
Cost
DR. INFO Free tier, paid plans
OpenEvidence Was free for verified clinicians
| DR. INFO | OpenEvidence | |
|---|---|---|
| Available in Austria | Yes, on the web and the iPhone app | No, access from the EU ended 28 April 2026 |
| Answers in German | Yes, in the language you ask in; German interface | No, English only |
| How it answers | A written answer built from retrieved guidelines and literature, each statement cited | A written answer with citations, US-oriented sources |
| Data hosting | European Union, under GDPR | United States |
| Guideline sources | European and national guidelines, retrieved per question, including the German-language S3 guidelines with Austrian participation | US-centred |
| Drug information | FDA and EMA authorised sources, EMA SmPC; the Austria-Codex remains the Austrian reference | US sources |
| Documentation | Scribe with SOAP notes and discharge letters in the same product | None |
| Regulatory status | CE marked medical device under EU MDR 2017/745, which applies directly in Austria | Not CE marked |
| HealthBench Hard (same 100 examples) | 0.72 | 0.49 |
| Cost | Free tier, paid plans | Was free for verified clinicians |
How DR. INFO compares with OpenEvidence
Rubric graded scores on difficult, open ended clinical conversations, from the same 100 example run. Higher is better.
Source: Ravichandran S, et al. OpenAI’s HealthBench in Action. arXiv:2509.02594.
Frequently asked questions
- Is OpenEvidence available in Austria in 2026?
- No. OpenEvidence terminated app access in the EU and the UK on 28 April 2026, and access from Austrian and other European addresses has been blocked since. The company cited regulatory uncertainty around European AI rules. No return date has been announced.
- Is OpenEvidence blocked in Austria, or is it an outage?
- It is a block, not an outage. Since 28 April 2026 OpenEvidence has refused access from the EU, and Austria is an EU member. Opening the site or the app from Vienna, Graz or Innsbruck returns no answer, whatever the device, account or network. Restarting does not help, because the service is deliberately unreachable from Europe.
- Is there a German version of OpenEvidence?
- No. OpenEvidence never answered in German or offered a German interface, and its sources were US-oriented. DR. INFO answers in the language you ask in, German included, and the product itself is available in German.
- Does the OpenEvidence app still work in Austria?
- No. The app can be installed, but sign-in and access from EU addresses have been blocked since April 2026, in the app and in the browser alike. DR. INFO works in the browser at app.drinfo.ai and on the iPhone app, from Austria without workarounds.
- When will OpenEvidence come to Austria?
- There is no date. The withdrawal was tied to European AI regulation, whose obligations for medical AI phase in through 2027, so a return would be a decision by the company rather than a technical fix. A clinician who needs a cited answer today is better off not waiting for it.
- Why did OpenEvidence leave Europe?
- OpenEvidence withdrew from the EU and the UK together, citing uncertainty about European AI regulation, including the EU AI Act. Commentary in the medical press has treated the move as a sign of the regulatory divide between US health AI and European rules [8].
- What do Austrian doctors use instead of OpenEvidence?
- Two kinds of tool. The Austrian references: the Austria-Codex with the summaries of product characteristics of every medicine authorised in Austria [4], the e-Medikation in ELGA for the patient's current medication [9], and the S3 guidelines in the AWMF register, many of which are written together with Austrian societies [5]. And DR. INFO, a European clinical AI that answers a clinical question with citations you can open, hosts data in the EU, and includes a scribe and discharge letter drafting.
- Is DR. INFO the best OpenEvidence alternative for Austrian doctors?
- For a clinician who wants what OpenEvidence did, a cited written answer to a clinical question, DR. INFO is the closest fit that can be used from Austria: it retrieves guidelines and literature for each question, cites every statement, hosts data in the EU, answers in German and scored 0.72 against OpenEvidence's 0.49 on HealthBench Hard.
- How does DR. INFO cite its answers?
- Each answer is written from documents retrieved for that question, and each statement carries a citation that opens the source: a guideline, a peer reviewed paper, or an FDA or EMA drug document. That makes the answer checkable in the way a colleague's summary is not. In a prospective pilot study published in Cureus in 2026, physicians using DR. INFO at the point of care rated that traceability as part of its value [10].
- Does DR. INFO cover Austrian guidelines?
- Austria has no central guideline register of its own like the AWMF. Many of the recommendations Austrian clinicians treat by are the German-language S3 guidelines that Austrian societies co-author, alongside European guidelines from the ESC, ESMO or KDIGO. DR. INFO retrieves these sources per question and answers in German; with the country set to Austria, national recommendations are preferred. Coverage is broad but not complete for any society; the source document is linked in every answer, and the current version remains authoritative.
- Where is the data hosted, and what does that mean for an Austrian practice or hospital?
- DR. INFO is hosted in the European Union under GDPR, which applies directly in Austria and is supplemented by the Datenschutzgesetz. Whether a tool may be used with identifiable patient data is still a decision for each Ordination, group practice and hospital, with medical confidentiality under the Ärztegesetz in mind. Asking a clinical question without patient identifiers does not transfer health data; for anything beyond that, the data protection officer is the right person to ask.
- Is DR. INFO free for doctors in Austria?
- There is a free tier for doctors, Turnusärzte and medical students, with paid plans for heavier use. It works in the browser at app.drinfo.ai and on the iPhone app, from Austria without restriction.
- Does using DR. INFO count towards DFP credit?
- No. DR. INFO is a working tool for daily practice, not an approved training activity. DFP points in Austria come only from activities approved by the Akademie der Ärzte and recorded on meindfp.at [11]. What DR. INFO contributes is the path to the guideline or the paper behind an answer; the reading and learning remain yours.
- Is DR. INFO a certified medical device?
- Yes. DR. INFO is CE marked under EU MDR 2017/745 [12], which applies directly in Austria with the Federal Office for Safety in Health Care as the competent authority. It is developed and operated by Synduct GmbH in Munich.
OpenEvidence is not coming to Austria on any announced date, there was never a German version, and the Austria-Codex was never an answer engine. For a clinician in practice, hospital or Turnus who wants a cited answer to a clinical question, DR. INFO is the tool to try first: built in Europe, hosted in the EU, in German, free to start, and scoring higher than OpenEvidence on the hardest public benchmark of clinical answers.
References
- 1.Breaking: OpenEvidence app access terminated in the UK and EU. Telehealth and Telecare Aware. 28 April 2026.
- 2.The US-based medical search engine OpenEvidence is down in Europe: a commentary on regulatory complexities. Intelligence-Based Medicine. 2026.
- 3.Österreichische Ärztekammer. Aktuelle Ärztestatistik: Trends, die in der Gesundheitspolitik bedacht werden sollten. Presseaussendung, 29. Juli 2026.
- 4.Österreichische Apotheker-Verlagsgesellschaft. Austria-Codex: Fachinformationen der in Österreich zugelassenen Arzneispezialitäten.
- 5.AWMF. Leitlinienregister: aktuelle Leitlinien der wissenschaftlichen medizinischen Fachgesellschaften.
- 6.Ravichandran S, Kumar S, Corga Da Silva R, Romano M, et al. OpenAI’s HealthBench in Action: Evaluating an LLM-Based Medical Assistant on Realistic Clinical Queries. arXiv:2509.02594. 2026.
- 7.Arora RK, Wei J, Soskin Hicks R, et al. HealthBench: Evaluating Large Language Models Toward Improved Human Health. OpenAI. 2025.
- 8.OpenEvidence exits Europe, highlighting divide in health AI rules. Telehealth.org. 2026.
- 9.ELGA GmbH. ELGA: die elektronische Gesundheitsakte in Österreich.
- 10.Corga Da Silva R, Romano M, Mendes T, et al. DR. INFO at the Point of Care: A Prospective Pilot Study of Physician-Perceived Value of an Agentic Artificial Intelligence Clinical Assistant. Cureus. 2026.
- 11.Österreichische Akademie der Ärzte. meindfp.at: das Diplom-Fortbildungs-Programm der Österreichischen Ärztekammer.
- 12.Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (EU MDR). Official Journal of the European Union. 2017.